Orchid Chemicals & Pharmaceuticals Ltd operates in the Pharmaceutical preparations sector. Orchid Chemicals & Pharmaceuticals Limited manufactures active pharmaceuticals ingredients (API) as 100% export oriented unit, and manufactures and sells finished dosage forms (formulations) in domestic and export markets. The Company's product portfolio consists of multiple therapeutic segments namely anti-infectives (oral and sterile), anti-inflammatory, central nervous system (CNS), cardio vascular system (CVS) and nutraceutical products. The Company has three API manufacturing sites, two in India (Chennai and Aurangabad) and one in China (joint venture). The API manufacturing complex located in Aurangabad, Maharashtra, provides multi-therapeutic product offerings, consists of high-end Bectalactams, Carbapenems and non-antibiotic APIs. During the fiscal year ended March 31, 2011, the Company acquired Karalex Pharma LLC. The Company has 50% joint venture with NCPC Orchid Pharmaceuticals Company Limited. In
our complete report available for purchase the company is compared to: Divi's Laboratories Limited, Surya Pharmaceutical Limited and Alembic Ltd.